Clinical Trial Update: Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders [Phase 1, Phase 2]

View source ↗

Summary

Descartes-08 by Cartesian Therapeutics is in Phase 1/2 and currently recruiting for pediatric/young adult trials in childhood-onset systemic lupus erythematosus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Childhood-onset Systemic Lupus Erythematosus
• Juvenile Dermatomyositis
• Juvenile Myasthenia Gravis

Drugs mentioned

• Descartes-08

Snippet

Sponsor: Cartesian Therapeutics | Conditions: Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV) | Phase 1, Phase 2 | Status: RECRUITING